Menkes Syndrome Market Expected to Surge with 8.5% CAGR, Reaching USD 0.5 Million by 2033
The Global Menkes Syndrome Market is anticipated to grow significantly over the next decade, with its market size projected to increase from USD 0.2 million in 2023 to USD 0.5 million by 2033, reflecting a compound annual growth rate (CAGR) of 8.5% during the forecast period from 2024 to 2033. This growth is driven by several key factors, including advancements in genetic testing and early diagnosis, which are crucial for effective treatment. The increased awareness and research into Menkes Syndrome have also contributed to market expansion, alongside the development of novel copper-based therapies. However, the market faces substantial challenges, such…
- Date: May 30, 2024
- Author: Robert Shaw
- Category: PharmiWeb